A

Angiex

Biotechnologyđź“Ť Cambridge, MA

Angiex develops antibody-based therapeutics, specifically first-in-class Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) targeting cancer lethality and pathological angiogenesis.

Visit website →View careers page →

Open Positions at Angiex

0 positions available

No open positions at the moment

Check back later for new opportunities!